During the past decade, Revita Reumatologiai Rendelo conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 11 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Revita Reumatologiai Rendelo" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Revita Reumatologiai Rendelo" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Revita Reumatologiai Rendelo" are "Rheumatoid Arthritis" (12 trials), "Arthritis, Rheumatoid" (4 trials), "Arthritis, Psoriatic" (2 trials), "Arthritis" (1 trials) and "Autoimmune Diseases" (1 trials). Many other conditions were trialed in "Revita Reumatologiai Rendelo" in a lesser frequency.

Most popular intervention types in "Revita Reumatologiai Rendelo" are "Drug" (21 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "CP-690,550" (3 trials), "Tofacitinib" (3 trials), "Baricitinib" (2 trials) and "GLPG0634" (2 trials). Other intervention names were less common.

The vast majority of trials in "Revita Reumatologiai Rendelo" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Revita Reumatologiai Rendelo". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Revita Reumatologiai Rendelo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Revita Reumatologiai Rendelo, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".